27 research outputs found

    Simulations magnétohydrodynamiques en régime idéal

    Get PDF
    Cette thĂšse s’intĂ©resse Ă  la modĂ©lisation magnĂ©tohydrodynamique des Ă©coulements de fluides conducteurs d’électricitĂ© multi-Ă©chelles en mettant l’emphase sur deux applications particuliĂšres de la physique solaire: la modĂ©lisation des mĂ©canismes des variations de l’irradiance via la simulation de la dynamo globale et la reconnexion magnĂ©tique. Les variations de l’irradiance sur les pĂ©riodes des jours, des mois et du cycle solaire de 11 ans sont trĂšs bien expliquĂ©es par le passage des rĂ©gions actives Ă  la surface du Soleil. Cependant, l’origine ultime des variations se dĂ©roulant sur les pĂ©riodes dĂ©cadales et multi-dĂ©cadales demeure un sujet controversĂ©. En particulier, une certaine Ă©cole de pensĂ©e affirme qu’une partie de ces variations Ă  long-terme doit provenir d’une modulation de la structure thermodynamique globale de l’étoile, et que les seuls effets de surface sont incapables d’expliquer la totalitĂ© des fluctuations. Nous prĂ©sentons une simulation globale de la convection solaire produisant un cycle magnĂ©tique similaire en plusieurs aspects Ă  celui du Soleil, dans laquelle le flux thermique convectif varie en phase avec l’ ́energie magnĂ©tique. La corrĂ©lation positive entre le flux convectif et l’énergie magnĂ©tique supporte donc l’idĂ©e qu’une modulation de la structure thermodynamique puisse contribuer aux variations Ă  long-terme de l’irradiance. Nous analysons cette simulation dans le but d’identifier le mĂ©canisme physique responsable de la corrĂ©lation en question et pour prĂ©dire de potentiels effets observationnels rĂ©sultant de la modulation structurelle. La reconnexion magnĂ©tique est au coeur du mĂ©canisme de plusieurs phĂ©nomĂšnes de la physique solaire dont les Ă©ruptions et les Ă©jections de masse, et pourrait expliquer les tempĂ©ratures extrĂȘmes caractĂ©risant la couronne. Une correction aux trajectoires du schĂ©ma semi-Lagrangien classique est prĂ©sentĂ©e, qui est basĂ©e sur la solution Ă  une Ă©quation aux dĂ©rivĂ©es partielles nonlinĂ©aire du second ordre: l’équation de Monge-AmpĂšre. Celle-ci prĂ©vient l’intersection des trajectoires et assure la stabilitĂ© numĂ©rique des simulations de reconnexion magnĂ©tique pour un cas de magnĂ©to-fluide relaxant vers un Ă©tat d’équilibre.This thesis concentrates on magnetohydrodynamical modeling of multiscale conducting fluids with emphasis on two particular applications of solar physics: the modeling of solar irradiance mechanisms via the numerical simulation of the global dynamo and of magnetic reconnection. Irradiance variations on the time scales of days, months, and of the 11 yr solar cycle are very well described by changes in the surface coverage by active regions. However, the ultimate origin of the long-term decadal and multi-decadal variations is still a matter of debate. In particular, one school of thought argues that a global modulation of the solar thermodynamic structure by magnetic activity is required to account for part of the long-term variations, in addition to pure surface effects. We hereby present a global simulation of solar convection producing solar-like magnetic cycles, in which the convective heat flux varies in phase with magnetic energy. We analyze the simulation to uncover the physical mechanism causing the positive correlation and to predict potential observational signatures resulting from the flux modulation. Magnetic reconnection is central to many solar physics phenomena including flares and coronal mass ejections, and could also provide an explanation for the extreme temperatures (T ∌ 106K) that charaterize the coronna. A trajectory correction to the classical semi-Lagrangian scheme is presented, which is based on the solution to a second-order nonlinear partial differential equation: the Monge-Amp`ere equation. Using the correction prevents the intersection of fluid trajectories and assures the physical realizability of magnetic reconnection simulations for the case of a magneto- fluid relaxing toward an equilibrium state

    Pharmacogenomics of the efficacy and safety of Colchicine in COLCOT

    Get PDF
    © 2021 The Authors. Circulation: Genomic and Precision Medicine is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited and is not used for commercial purposes.Background: The randomized, placebo-controlled COLCOT (Colchicine Cardiovascular Outcomes Trial) has shown the benefits of colchicine 0.5 mg daily to lower the rate of ischemic cardiovascular events in patients with a recent myocardial infarction. Here, we conducted a post hoc pharmacogenomic study of COLCOT with the aim to identify genetic predictors of the efficacy and safety of treatment with colchicine. Methods: There were 1522 participants of European ancestry from the COLCOT trial available for the pharmacogenomic study of COLCOT trial. The pharmacogenomic study's primary cardiovascular end point was defined as for the main trial, as time to first occurrence of cardiovascular death, resuscitated cardiac arrest, myocardial infarction, stroke, or urgent hospitalization for angina requiring coronary revascularization. The safety end point was time to the first report of gastrointestinal events. Patients' DNA was genotyped using the Illumina Global Screening array followed by imputation. We performed a genome-wide association study in colchicine-treated patients. Results: None of the genetic variants passed the genome-wide association study significance threshold for the primary cardiovascular end point conducted in 702 patients in the colchicine arm who were compliant to medication. The genome-wide association study for gastrointestinal events was conducted in all 767 patients in the colchicine arm and found 2 significant association signals, one with lead variant rs6916345 (hazard ratio, 1.89 [95% CI, 1.52-2.35], P=7.41×10-9) in a locus which colocalizes with Crohn disease, and one with lead variant rs74795203 (hazard ratio, 2.51 [95% CI, 1.82-3.47]; P=2.70×10-8), an intronic variant in gene SEPHS1. The interaction terms between the genetic variants and treatment with colchicine versus placebo were significant. Conclusions: We found 2 genomic regions associated with gastrointestinal events in patients treated with colchicine. Those findings will benefit from replication to confirm that some patients may have genetic predispositions to lower tolerability of treatment with colchicine.info:eu-repo/semantics/publishedVersio

    Analysis of shared common genetic risk between amyotrophic lateral sclerosis and epilepsy

    Get PDF
    Because hyper-excitability has been shown to be a shared pathophysiological mechanism, we used the latest and largest genome-wide studies in amyotrophic lateral sclerosis (n = 36,052) and epilepsy (n = 38,349) to determine genetic overlap between these conditions. First, we showed no significant genetic correlation, also when binned on minor allele frequency. Second, we confirmed the absence of polygenic overlap using genomic risk score analysis. Finally, we did not identify pleiotropic variants in meta-analyses of the 2 diseases. Our findings indicate that amyotrophic lateral sclerosis and epilepsy do not share common genetic risk, showing that hyper-excitability in both disorders has distinct origins

    Analysis of shared heritability in common disorders of the brain

    Get PDF
    ience, this issue p. eaap8757 Structured Abstract INTRODUCTION Brain disorders may exhibit shared symptoms and substantial epidemiological comorbidity, inciting debate about their etiologic overlap. However, detailed study of phenotypes with different ages of onset, severity, and presentation poses a considerable challenge. Recently developed heritability methods allow us to accurately measure correlation of genome-wide common variant risk between two phenotypes from pools of different individuals and assess how connected they, or at least their genetic risks, are on the genomic level. We used genome-wide association data for 265,218 patients and 784,643 control participants, as well as 17 phenotypes from a total of 1,191,588 individuals, to quantify the degree of overlap for genetic risk factors of 25 common brain disorders. RATIONALE Over the past century, the classification of brain disorders has evolved to reflect the medical and scientific communities' assessments of the presumed root causes of clinical phenomena such as behavioral change, loss of motor function, or alterations of consciousness. Directly observable phenomena (such as the presence of emboli, protein tangles, or unusual electrical activity patterns) generally define and separate neurological disorders from psychiatric disorders. Understanding the genetic underpinnings and categorical distinctions for brain disorders and related phenotypes may inform the search for their biological mechanisms. RESULTS Common variant risk for psychiatric disorders was shown to correlate significantly, especially among attention deficit hyperactivity disorder (ADHD), bipolar disorder, major depressive disorder (MDD), and schizophrenia. By contrast, neurological disorders appear more distinct from one another and from the psychiatric disorders, except for migraine, which was significantly correlated to ADHD, MDD, and Tourette syndrome. We demonstrate that, in the general population, the personality trait neuroticism is significantly correlated with almost every psychiatric disorder and migraine. We also identify significant genetic sharing between disorders and early life cognitive measures (e.g., years of education and college attainment) in the general population, demonstrating positive correlation with several psychiatric disorders (e.g., anorexia nervosa and bipolar disorder) and negative correlation with several neurological phenotypes (e.g., Alzheimer's disease and ischemic stroke), even though the latter are considered to result from specific processes that occur later in life. Extensive simulations were also performed to inform how statistical power, diagnostic misclassification, and phenotypic heterogeneity influence genetic correlations. CONCLUSION The high degree of genetic correlation among many of the psychiatric disorders adds further evidence that their current clinical boundaries do not reflect distinct underlying pathogenic processes, at least on the genetic level. This suggests a deeply interconnected nature for psychiatric disorders, in contrast to neurological disorders, and underscores the need to refine psychiatric diagnostics. Genetically informed analyses may provide important "scaffolding" to support such restructuring of psychiatric nosology, which likely requires incorporating many levels of information. By contrast, we find limited evidence for widespread common genetic risk sharing among neurological disorders or across neurological and psychiatric disorders. We show that both psychiatric and neurological disorders have robust correlations with cognitive and personality measures. Further study is needed to evaluate whether overlapping genetic contributions to psychiatric pathology may influence treatment choices. Ultimately, such developments may pave the way toward reduced heterogeneity and improved diagnosis and treatment of psychiatric disorders

    End-of-life CDTE PV recycling with semiconductor refining

    No full text

    Impact d’un guide d’antibioprophylaxie chirurgicale pour les cholĂ©cystectomies et les hystĂ©rectomies en Ă©tablissement de santĂ©

    No full text
    RĂ©sumĂ© Il s’agit d’une Ă©tude quasi expĂ©rimentale de type prĂ© et post qui Ă©value l’impact de l’implantation d’un nouveau guide d’utilisation des antibiotiques en prophylaxie pour l’hystĂ©rectomie et la cholĂ©cystectomie. L’étude a permis de recruter 663 sujets, dont 601 ont Ă©tĂ© inclus dans notre analyse. On observe que le recours Ă  l’antibioprophylaxie, selon les recommandations proposĂ©es, est conforme dans 54 % des cas dans le groupe prĂ©intervention contre 66 % dans le groupe postintervention, une diffĂ©rence statistiquement significative (p = 0,003). Parmi les patients ayant reçu des antibiotiques (n = 270), on note que la conformitĂ© globale (c’est-Ă -dire pour les quatre critĂšres combinĂ©s, soit le choix, la dose, le dĂ©lai et le lieu) passe de 31 % avant l’implantation du guide Ă  39 % aprĂšs (p = 0,15). De mĂȘme, aucune diffĂ©rence significative n’est observĂ©e entre les taux de conformitĂ© pour chacun des critĂšres entre le groupe prĂ© et le groupe post. Le taux de conformitĂ© global est plus Ă©levĂ© pour les cholĂ©cystectomies (59 %) que pour les hystĂ©rectomies (27 %) (p < 0,001). Au niveau des coĂ»ts, on observe une rĂ©duction significative de la moyenne des coĂ»ts pour l’ensemble des patients inclus dans l’étude entre le groupe contrĂŽle (n = 301 – coĂ»t moyen 3,03 ±2,16)etlegroupeexpeˊrimental(2,56 ± 2,16) et le groupe expĂ©rimental (2,56 ± 2,18) (p = 0,01, test de t). La diffĂ©rence n’est toutefois plus significative quand on considĂšre uniquement les patients ayant reçu une antibioprophylaxie entre le groupe contrĂŽle (n = 121 – coĂ»t moyen 3,75 ±6,22)etlegroupeexpeˊrimental(n=149–2,63 ± 6,22) et le groupe expĂ©rimental (n = 149 – 2,63 ± 3,32) (p = 0,06, test de t). Bien que l’utilisation d’antibiotiques en prophylaxie chirurgicale ait Ă©tĂ© largement Ă©tudiĂ©e, on observe un taux de conformitĂ© limitĂ© par rapport aux lignes directrices publiĂ©es. MĂȘme si nous n’avons pas observĂ© de diffĂ©rences quant Ă  tous les paramĂštres de conformitĂ© Ă  la suite de l’implantation du protocole, une intervention ponctuelle des pharmaciens peut contribuer Ă  amĂ©liorer globalement la conformitĂ© de l’antibioprophylaxie en Ă©tablissement de santĂ©. Abstract This pre-post quasi-experimental study assesses the impact of the implementation of a new guide on prophylactic antibiotics use for hysterectomy and cholecystectomy. 663 subjects have been recruited, from which 601 have been included in our analysis. Antibioprophylaxis is used in accordance with the suggested guidelines in 54% of cases in the preintervention group, compared to 66% in the postintervention group, a statistically significant difference (p = 0.003). Among patients that have been treated with antibiotics (n = 270), global conformity (combination of the four criteria: choice, dose, administration time and place) goes from 31% before implementation of the guide to 39% afterwards (p = 0.15). Likewise, among pre and post groups, no statistically significant difference was noted between conformity rates for each of the criteria. Global conformity rate is higher for cholecystectomies (59%) than for hysterectomies (27%) (p < 0.001). As for costs, we note a significant decrease of the average cost as a whole between the control group (n = 301 – average cost 3.03±2.16)andtheexperimentalgroup(3.03 ± 2.16) and the experimental group (2.56 ± 2.18) (p = 0.01, t-test). However, this difference is no longer significant if we only take into account patients who have received antibioprophylaxis, between the control group (n = 121 – average cost 3.75±6.22)andtheexperimentalgroup(n=149–averagecost3.75 ± 6.22) and the experimental group (n = 149 – average cost 2.63 ± 3.32) (p = 0.06, t-test). Although the use of antibiotics in surgical prophylaxis has been widely studied, we observe a limited conformity rate in relation to published guidelines. Despite the fact that we have not noticed any difference as to all conformity parameters following protocol implementation, a punctual intervention by the pharmacists may contribute to improve global conformity to antibioprophylaxis in healthcare facilities

    L'autre transparence : Oeuvres holographiques, 6 artistes du Québec : Boissonnet, Cantin, Cossette, Dyens, Evergon, Mathieu

    No full text
    For the presentation of holograms by six Québec artists, Boissonnet and Fischer give evidence of the evolution of holography as an artistic form. Brief artists' statements. Biographical notes
    corecore